Allegretti Jessica R, Korzenik Joshua R, Hamilton Matthew J
Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital;
Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital.
J Vis Exp. 2014 Dec 8(94):52154. doi: 10.3791/52154.
Fecal Microbiota Transplantation (FMT) is a safe and highly effective treatment for recurrent and refractory C. difficile infection (CDI). Various methods of FMT administration have been reported in the literature including nasogastric tube, upper endoscopy, enema and colonoscopy. FMT via colonoscopy yields excellent cure rates and is also well tolerated. We have found that patients find this an acceptable and tolerable mode of delivery. At our Center, we have initiated a fecal transplant program for patients with recurrent or refractory CDI. We have developed a protocol using an iterative process of revision and have performed 24 fecal transplants on 22 patients with success rates comparable to the current published literature. A systematic approach to patient and donor screening, preparation of stool, and delivery of the stool maximizes therapeutic success. Here we detail each step of the FMT protocol that can be carried out at any endoscopy center with a high degree of safety and success.
粪便微生物群移植(FMT)是治疗复发性和难治性艰难梭菌感染(CDI)的一种安全且高效的疗法。文献中报道了多种FMT给药方法,包括鼻胃管、上消化道内镜检查、灌肠和结肠镜检查。通过结肠镜检查进行FMT治愈率极高,且耐受性良好。我们发现患者认为这种给药方式是可接受且可耐受的。在我们中心,我们已为复发性或难治性CDI患者启动了一项粪便移植计划。我们制定了一个通过反复修订的方案,并已对22名患者进行了24次粪便移植,成功率与当前已发表的文献相当。对患者和供体进行筛查、粪便制备以及粪便输送的系统方法可使治疗成功率最大化。在此,我们详细介绍FMT方案的每一个步骤,这些步骤可在任何内镜中心以高度的安全性和成功率进行。